ArticleCurrent oncology (Toronto, Ont.)2024

Real-World Efficacy and Safety of Avelumab Plus Axitinib in Metastatic Renal Cell Carcinoma: Results from the Ambispective RAVE-Renal Study.

Ilya Tsimafeyeu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.